Celera (CRA) and Medco (MHS) Enter Research Collaboration to Evaluate Effect of KIF6 Testing on Compliance with Statin Therapy in Patients with Cardiovascular Disease
Tweet Send to a Friend
Celera Corporation (NASDAQ: CRA) and Medco Health Solutions, Inc. (NYSE: MHS), today announced that they have entered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
